Authors:
CORAZZA M
MANTOVANI L
BERTELLI G
VIRGILI A
Citation: M. Corazza et al., A GOLDSMITH WITH OCCUPATIONAL ALLERGIC CONTACT-DERMATITIS DUE TO ETHYLENEDIAMINE IN A DETERGENT, Contact dermatitis, 38(6), 1998, pp. 350-351
Authors:
BONIFACI C
CECCON A
GAMBARO A
MANOLI F
MANTOVANI L
GANIS P
SANTI S
VENZO A
Citation: C. Bonifaci et al., INDENYL AND INDACENYL LIGANDS IN HOMO AND HETEROBIMETALLIC COMPLEXES, Journal of organometallic chemistry, 557(1), 1998, pp. 97-109
Authors:
MANTOVANI L
HENSCHLER R
BRACH M
MERTELSMANN RH
HERRMANN F
Citation: L. Mantovani et al., REGULATION OF GENE-EXPRESSION OF MACROPHAGE-COLONY-STIMULATING FACTORIN HUMAN FIBROBLASTS BY THE ACUTE-PHASE RESPONSE MEDIATORS INTERLEUKIN (IL)-1-BETA, TUMOR-NECROSIS-FACTOR-ALPHA AND IL-6 (VOL 280, PG 97, 1991), FEBS letters, 429(3), 1998, pp. 426-426
Authors:
MANTOVANI L
HENSCHLER R
BRACH M
WIESER R
LUBBERT M
LINDEMANN A
MERTELSMANN RH
HERRMANN F
Citation: L. Mantovani et al., DIFFERENTIAL REGULATION OF INTERLEUKIN-6 EXPRESSION IN HUMAN FIBROBLASTS BY TUMOR-NECROSIS-FACTOR-ALPHA AND LYMPHOTOXIN (VOL 270, PG 156, 1990), FEBS letters, 429(3), 1998, pp. 426-426
Authors:
LEIBLEIN S
PONISCH W
KURSCHNER D
EDEL E
ULRICH E
KRAHL R
BECKER C
MANTOVANI L
FRIEDRICH T
HEROLD M
FIEDLER F
SCHWALBE V
KUBEL M
HEBIG W
Citation: S. Leiblein et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN INTENSIVELY PRETREATED PATIENTS WITH AML, British Journal of Haematology, 102(1), 1998, pp. 70-71
Authors:
LANGE T
SCHWENKE H
TAUCHNITZ R
POENISCH W
SCHWARZER A
MANTOVANI L
HELBIG W
Citation: T. Lange et al., A RANDOMIZED SINGLE-CENTER PHASE-III TRIAL WITH PIPERACILLIN SULBACTAM AND CEFTAZIDIME AS FIRST-LINE TREATMENT FOR 103 FEBRILE EPISODES IN PATIENTS WITH SEVERE NEUTROPENIA/, British Journal of Haematology, 102(1), 1998, pp. 94-95
Authors:
PENNA A
GRILLI R
FILARDO G
MAININI F
ZOLA P
MANTOVANI L
LIBERATI A
Citation: A. Penna et al., DO DIFFERENT PHYSICIANS PANELS REACH SIMILAR CONCLUSIONS - A CASE-STUDY ON PRACTICE GUIDELINES FOR LIMITED SURGERY IN BREAST-CANCER, European journal of public health, 7(4), 1997, pp. 436-440
Authors:
DINARDO A
GIUSTI G
MANTOVANI L
BIANCHI B
SEIDENARI S
Citation: A. Dinardo et al., INHIBITION OF ELICITATION OF CONTACT-DERMATITIS IN HUMANS BY MOMETASONE FUROATE - EVALUATION BY MEANS OF 20-MHZ B-SCANNING ASSOCIATED WITH IMAGE-ANALYSIS, Dermatology, 195(2), 1997, pp. 137-141
Authors:
SCHMITT C
HENRYLAUNOIS B
JOLAIN B
CAVALLO MC
MANTOVANI L
Citation: C. Schmitt et al., A MODEL OF PATIENTS PREFERENCES FOR CHEMOTHERAPY OUTCOMES IN ADVANCEDCOLORECTAL-CANCER - DO GAINS IN SURVIVAL JUSTIFY THE TOXICITY, European journal of cancer, 33, 1997, pp. 56-56
Authors:
SEIDENARI S
DINARDO A
MANTOVANI L
GIANNETTI A
Citation: S. Seidenari et al., PARALLEL INTRAINDIVIDUAL EVALUATION OF THE VASOCONSTRICTORY ACTION AND THE ANTIALLERGIC ACTIVITY OF TOPICAL CORTICOSTEROIDS, Experimental dermatology, 6(2), 1997, pp. 75-80
Authors:
MANTOVANI L
CECCON A
GAMBARO A
SANTI S
GANIS P
VENZO A
Citation: L. Mantovani et al., HETEROBIMETALLIC INDENYL COMPLEXES - MECHANISM OF CYCLOTRIMERIZATION OF DIMETHYL ACETYLENEDICARBOXYLATE (DMAD) CATALYZED BY TRANS-[CR(CO)(3)(HEPTAMETHYLINDENYL)RH(CO)(2)], Organometallics, 16(12), 1997, pp. 2682-2690
Authors:
SEIDENARI S
MANTOVANI L
MANZINI BM
PIGNATTI M
Citation: S. Seidenari et al., CROSS-SENSITIZATIONS BETWEEN AZO DYES AND PARA-AMINO COMPOUND - A STUDY OF 236 AZO-DYE-SENSITIVE SUBJECTS, Contact dermatitis, 36(2), 1997, pp. 91-96
Authors:
SEIDENARI S
BELLETTI B
MANTOVANI L
PELLACANI G
PIGNATTI M
Citation: S. Seidenari et al., COMPARISON OF 2 DIFFERENT METHODS FOR ENHANCING THE REACTION TO NICKEL SULFATE PATCH TESTS IN NEGATIVE REACTORS, Contact dermatitis, 35(5), 1996, pp. 308-308
Authors:
SEIDENARI S
BELLETTI B
MANTOVANI L
PEPE P
Citation: S. Seidenari et al., NICKEL SULFATE 5-20-PERCENT AQ DOES NOT EVOKE IRRITATION ON THE SKIN OF NON-NICKEL-SENSITIVE SUBJECTS, Contact dermatitis, 35(4), 1996, pp. 260-261
Authors:
CORAZZA M
MANTOVANI L
CASETTA I
VIRGILI A
Citation: M. Corazza et al., EXFOLIATIVE DERMATITIS CAUSED BY CARBAMAZEPINE IN A PATIENT WITH ISOLATED IGA DEFICIENCY, Contact dermatitis, 33(6), 1995, pp. 447-447
Authors:
MANTOVANI L
KAMPFE D
LEHMANN P
PONISCH W
LEIBLEIN S
WOLKERSDORF G
SCHULZE F
SCHWENKE H
HELBIG W
Citation: L. Mantovani et al., TREATMENT OF POOR-PROGNOSIS AML WITH RHGM-CSF AND RHG-CSF FOR PRIMING, FOLLOWED BY CYTARABINE PLUS MITOXANTRONE INDUCTION THERAPY - A PHASEI II STUDY/, Blood, 86(10), 1995, pp. 3062-3062